Literature DB >> 18383071

Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?

Joseph Jankovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18383071     DOI： 10.1002/ana.21348

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

1.  Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors.

Authors:  Cristina Roseti; Katiuscia Martinello; Sergio Fucile; Vanessa Piccari; Addolorata Mascia; Giancarlo Di Gennaro; Pier Paolo Quarato; Mario Manfredi; Vincenzo Esposito; Gianpaolo Cantore; Antonella Arcella; Michele Simonato; Bertil B Fredholm; Cristina Limatola; Ricardo Miledi; Fabrizio Eusebi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

Review 2.  Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.

Authors:  Xuesong Chen; Othman Ghribi; Jonathan D Geiger
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Chocolate consumption is increased in Parkinson's disease. Results from a self-questionnaire study.

Authors:  Martin Wolz; Alice Kaminsky; Matthias Löhle; Rainer Koch; Alexander Storch; Heinz Reichmann
Journal:  J Neurol       Date:  2009-03-13       Impact factor: 4.849

4.  Comparison of chocolate to cacao-free white chocolate in Parkinson's disease: a single-dose, investigator-blinded, placebo-controlled, crossover trial.

Authors:  Martin Wolz; Christine Schleiffer; Lisa Klingelhöfer; Christine Schneider; Florian Proft; Uta Schwanebeck; Heinz Reichmann; Peter Riederer; Alexander Storch
Journal:  J Neurol       Date:  2012-05-15       Impact factor: 4.849

5.  Current approaches to the treatment of Parkinson's disease.

Authors:  Joseph Jankovic; L Giselle Aguilar
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

6.  Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  J Guridi; R González-Redondo; J A Obeso
Journal:  Parkinsons Dis       Date:  2012-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.